Torrent Pharma is a Torrent Group company. Company is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. Its Research Center employs over 580 scientists in the areas of drug discovery and development. A 2300 strong field force caters to around 2,00,000 doctors across the country, which makes it rank fifth in terms of market reach.
Torrent Pharma exports to more than 50 countries around the world with over 1000 product registrations. The international business has been broadly divided into five zones- USA, Latin America, Russia and CIS, Western Europe and CEE and Rest of the World (ROW).
Consolidated Yearly Financials (Rs in Crore)
Consolidated Quarterly Financials (Rs in Crore)
Any purchase/sale of a stock involves a high degree of investment risk. Caution all investors that they may lose some or all of their investment if they decide to purchase any stock listed here.